Hi Arnies,
I was working off Phillipers post #40960748 Patients USA, Europe & Japan from presentation totalling 119k patients (actual estimates of patients <60at in report slide 8 is 223k) but at $240k per person p.a using 119k patients giving global end market of $28.5 billion, 2 drugs across 5 spectrums.
So I think Phillier has been conservative from actual report quoted patients
Under current deal with Acadia ie. double digit royalties (ie using 10%, actual digits of Acadia deal tbc) and assuming ROW is structured similar=10% of $28billion is $2.8 billion in royalties to Neu if this estimate in presentation is reached! ( double digits could be higher than 10% in Acadia deal tbc and ROW royalties could be lower than double digits or same given respectable $$ upfront is expected)
In addition to reducing patient numbers, I was conservatively halving it from $2.8b to $1.4billion royalties globally to be conservative (not ramp) (and as cost at $240k pp seems high) which actually is just current US deal with Acadia if you like. Not including ROW.
Get your point, for arguments sake half it again at $700m aud in revenue p.a in royalties to Neu, what is our MC worth with 100m shares on issue ( given Acadia is $11b US off $300m US revenue from sales of Nuz to date and growing but has way more than 100m shares issued)
- Forums
- ASX - By Stock
- Ann: Neuren Corporate Presentation, October 2019
Hi Arnies,I was working off Phillipers post #40960748 Patients...
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.33 |
Change
-0.170(0.87%) |
Mkt cap ! $2.487B |
Open | High | Low | Value | Volume |
$19.50 | $19.59 | $19.30 | $2.488M | 128.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 49 | $19.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.35 | 42 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 98 | 19.360 |
9 | 419 | 19.340 |
4 | 234 | 19.330 |
3 | 278 | 19.320 |
6 | 545 | 19.310 |
Price($) | Vol. | No. |
---|---|---|
19.370 | 202 | 4 |
19.380 | 274 | 5 |
19.390 | 374 | 5 |
19.400 | 266 | 3 |
19.410 | 694 | 5 |
Last trade - 12.46pm 10/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online